All Stories

  1. Neuropeptide Y (NPY) as a therapeutic target for neurodegenerative diseases
  2. Caloric restriction stimulates autophagy in rat cortical neurons through neuropeptide Y and ghrelin receptors activation
  3. The pathophysiology of defective proteostasis in the hypothalamus — from obesity to ageing
  4. Antileishmanial activity of antiretroviral drugs combined with miltefosine
  5. Caloric restriction blocks neuropathology and motor deficits in Machado–Joseph disease mouse models through SIRT1 pathway
  6. Neuropeptide Y alleviates Machado–Joseph disease
  7. Neuropeptide Y 1 and Y 5 receptors activation stimulate autophagic flux in mouse hypothalamic neurons
  8. Neuropeptide Y: An Anti-Aging Player?
  9. Emerging Role of Sirtuin 2 in the Regulation of Mammalian Metabolism
  10. Impaired adrenal medullary function in a mouse model of depression induced by unpredictable chronic stress
  11. Neuropeptide Y mitigates neuropathology and motor deficits in mouse models of Machado–Joseph disease
  12. Neuropeptide Y system in the retina: From localization to function
  13. NPY/neuropeptide Y enhances autophagy in the hypothalamus: a mechanism to delay aging?
  14. Neuropeptide Y stimulates autophagy in hypothalamic neurons
  15. Hypothalamic involvement in premature aging laminopathies
  16. Fluoxetine Induces Proliferation and Inhibits Differentiation of Hypothalamic Neuroprogenitor Cells In Vitro
  17. Role of hypothalamic neurogenesis in feeding regulation
  18. MicroRNAs in Obesity and Metabolism
  19. Catecholamine Release Modulation by Adenosine Through A2a Receptors in Mouse Chromaffin Cells in Culture
  20. Catecholamine Release Modulation by Adenosine through A2AReceptors in Mouse Chromaffin Cell Culture
  21. Chronic Unpredictable Stress Induces Catecholaminergic System Changes in Mouse Adrenal Gland
  22. Emerging novel roles of neuropeptide Y in the retina: From neuromodulation to neuroprotection
  23. Effect of Diabetes/Hyperglycemia on the Rat Retinal Adenosinergic System
  24. Neuropeptide Y Receptors Y 1 and Y 2 are Present in Neurons and Glial Cells in Rat Retinal Cells in Culture
  25. Dipeptidyl-peptidase-IV by cleaving neuropeptide Y induces lipid accumulation and PPAR-γ expression
  26. Regulation of catecholamine release in human adrenal chromaffin cells by β-adrenoceptors
  27. Effects of 3,4-Methylenedioxymethamphetamine Administration on Retinal Physiology in the Rat
  28. Gold nanoparticle-based fluorescence immunoassay for malaria antigen detection
  29. Moderate Long-Term Modulation of Neuropeptide Y in Hypothalamic Arcuate Nucleus Induces Energy Balance Alterations in Adult Rats
  30. Proliferative Hypothalamic Neurospheres Express NPY, AGRP, POMC, CART and Orexin-A and Differentiate to Functional Neurons
  31. Neuropeptide Y inhibits [Ca2+]ichanges in rat retinal neurons through NPY Y1, Y4, and Y5receptors
  32. Regulation of catecholamine release and tyrosine hydroxylase in human adrenal chromaffin cells by interleukin-1β: role of neuropeptide Y and nitric oxide
  33. Neuropeptide Y Family Peptides
  34. Role of adenosine a2a receptor and chronic stress on adrenal catecholamine regulation
  35. Stress-Induced Hypertension and Increased Sympathetic Activity in Mice Overexpressing Neuropeptide Y in Noradrenergic Neurons
  36. Neuropeptide Y stimulates retinal neural cell proliferation - involvement of nitric oxide
  37. Intracellular signaling mechanisms mediating catecholamine release upon activation of NPY Y1receptors in mouse chromaffin cells
  38. NPY in rat retina is present in neurons, in endothelial cells and also in microglial and Müller cells
  39. NPY Y1 receptor is not involved in the hemodynamic response to an acute cold pressor test in mice
  40. Neuropeptide Y regulates catecholamine release evoked by interleukin-1β in mouse chromaffin cells
  41. Neuropeptide Y expression, localization and cellular transducing effects in HUVEC
  42. Up-regulation of neuropeptide Y levels and modulation of glutamate release through neuropeptide Y receptors in the hippocampus of kainate-induced epileptic rats
  43. NPY, NPY receptors, and DPP IV activity are modulated by LPS, TNF-α and IFN-γ in HUVEC
  44. Blood sampling methodology is crucial for precise measurement of plasma catecholamines concentrations in mice
  45. Angiotensin II mediates catecholamine and neuropeptide Y secretion in human adrenal chromaffin cells through the AT1 receptor
  46. Neuropeptide Y and its receptors as potential therapeutic drug targets
  47. Catecholamine and Neuropeptide Y Secretion from Human Adrenal Chromaffin Cells
  48. Differential Secretion of Catecholamine and Neuropeptide Y in Response to KCl from Mice Chromaffin Cells
  49. Dibasic cleavage site is required for sorting to the regulated secretory pathway for both pro- and neuropeptide Y
  50. NPY Regulates Catecholamine Secretion from Human Adrenal Chromaffin Cells
  51. Cardiovascular effects of fentanyl in conscious rats